SAN DIEGO, Feb. 27, 2024 /PRNewswire/ Avidity Biosciences, Inc. , a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates ,.
27.02.2024 - BOSTON, Feb. 27, 2024 (GLOBE NEWSWIRE) - Ikena Oncology, Inc. (Nasdaq: IKNA, “Ikena,” “Company”), a targeted oncology company forging new territory in patient-directed cancer treatment, today announced that management will participate in a .
Nuvalent Highlights Pipeline Progress, Reiterates Key Anticipated Milestones And Reports Fourth Quarter And Full Year 2023 Financial Results menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.